Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic effects of different concentrations of ropivacaine for spinal anesthesia in elderly patients
ChiCTR2600125480Phase 4Not yet recruiting
- Sponsor
- Zhejiang Xiaoshan Hospital
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in None (2 arms), sponsored by Zhejiang Xiaoshan Hospital. Primary endpoint: Incidence of hypotension within 20 minutes after spinal anesthesia. Planned start May 2026; status: not yet recruiting.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on ChiCTR2600125480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125480.